Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T81331 |
QL-1200186
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
QL-1200186为具备口服活性与选择性的TYK2抑制剂。经口服后,该药剂量依赖性抑制因interleukin-12刺激所诱导的interferon-γ产生,并在银屑病模型小鼠中显著改善皮肤病变状况。 |